publication venue for
- 34 Gene Editing/Gene Therapies: ENHANCED MITOCHONDRIAL BASE EDITING SYSTEM FOR NEAR COMPLETE MITOCHONDRIAL GENOME EDITING IN HUMAN PRIMARY CELLS SUITABLE FOR DISEASE MODELING AND FOR POTENTIAL THERAPEUTIC APPLICATIONS. 25:s25-S25. 2023
- Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.. 19:28-35. 2017
- The exciting prospects of new therapies with mesenchymal stromal cells.. 19:1-8. 2017
- Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice.. 17:1332-1341. 2015
- PLX-PAD cell treatment mitigate toll-like receptor induced preeclampsia symptomology in mice. 16:s101-S101. 2014
- Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions.. 16:1486-1500. 2014
- A long-awaited discovery: hypoxia prevents mouse cells from undergoing spontaneous p53-dependent transformation.. 14:1029-1031. 2012
- Defining the risks of mesenchymal stromal cell therapy.. 12:576-578. 2010
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. 8:315-317. 2006
- Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells.. 3:393-396. 2001